Arkolith/Insider Trading/NVCR/Form 4

Paravasthu Mukund

Chief Operating OfficerNovoCure Ltd (NVCR) · full profile →Form 4 · filed Mar 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$667K
Net Open-Market Flow
-$667K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2026Sell(S)43K$13.77$595K73K
Mar 4, 2026Sell(S)5K$13.31$72K116K
Mar 3, 2026Grant(A)45K—$0121K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2026Grant(A)8K—$08K
Mar 3, 2026Grant(A)58K—$066K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002039078-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML